CLINICAL_TRIALS
trial_result
· 2009-09-18
Clinical Trial Update: GEM05 for Patients With Multiple Myeloma Under 65 Years [Phase 3]
Summary
A Phase 3 clinical trial named GEM05 for patients with multiple myeloma under 65 years has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PETHEMA Foundation | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED